Drugs that reverse disease transcriptomic signatures are more effective in a mouse model of dyslipidemia
Abstract High‐throughput omics have proven invaluable in studying human disease, and yet day‐to‐day clinical practice still relies on physiological, non‐omic markers. The metabolic syndrome, for example, is diagnosed and monitored by blood and urine indices such as blood cholesterol levels. Neverthe...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer Nature
2015-03-01
|
| Series: | Molecular Systems Biology |
| Subjects: | |
| Online Access: | https://doi.org/10.15252/msb.20145486 |